1. Home
  2. SOC vs INSP Comparison

SOC vs INSP Comparison

Compare SOC & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SOC

Sable Offshore Corp.

N/A

Current Price

$4.78

Market Cap

1.6B

Sector

N/A

ML Signal

N/A

Logo Inspire Medical Systems Inc.

INSP

Inspire Medical Systems Inc.

N/A

Current Price

$61.68

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SOC
INSP
Founded
2020
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
SOC
INSP
Price
$4.78
$61.68
Analyst Decision
Buy
Buy
Analyst Count
4
16
Target Price
$17.33
$94.00
AVG Volume (30 Days)
8.8M
556.8K
Earning Date
05-14-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
54.61
179.43
EPS
N/A
N/A
Revenue
N/A
$82,050,000.00
Revenue This Year
N/A
$8.02
Revenue Next Year
$73.55
$8.11
P/E Ratio
N/A
N/A
Revenue Growth
N/A
62.18
52 Week Low
$2.88
$38.91
52 Week High
$24.96
$147.03

Technical Indicators

Market Signals
Indicator
SOC
INSP
Relative Strength Index (RSI) 48.10 59.68
Support Level $3.97 $56.50
Resistance Level $5.38 $62.26
Average True Range (ATR) 0.35 2.27
MACD 0.08 -0.17
Stochastic Oscillator 56.19 75.43

Price Performance

Historical Comparison
SOC
INSP

About SOC Sable Offshore Corp.

Sable Offshore Corp is a Houston-based independent upstream company focused on developing the Santa Ynez Unit in federal waters offshore California. The company operates as one reportable oil and gas segment and is engaged in the acquisition, development, exploration, and production of oil and natural gas.

About INSP Inspire Medical Systems Inc.

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.

Share on Social Networks: